CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents

Platinum sensitivity is an important prognostic factor in patients with ovarian cancer. Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core member of the nucleosome remodeling and deacetylase complex, which functions as a chromatin remodeler. Emerging evidence indicates that CHD4 could be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyama, Yoshiko, Shigeta, Shogo, Tokunaga, Hideki, Tsuji, Keita, Ishibashi, Masumi, Shibuya, Yusuke, Shimada, Muneaki, Yasuda, Jun, Yaegashi, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221472/
https://www.ncbi.nlm.nih.gov/pubmed/34161330
http://dx.doi.org/10.1371/journal.pone.0251079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221472/
https://www.ncbi.nlm.nih.gov/pubmed/34161330
http://dx.doi.org/10.1371/journal.pone.0251079

Ejemplares similares